Eikon Therapeutics, Inc. - EIKN
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| UBS Group AG | History | New | 99,408 | 1,051 | 0.0% | — | 1 | +99,408 | New | Q1 2026 | May 05, 2026 |
| SEVEN GRAND MANAGERS, LLC | History | New | 80,000 | 846 | 0.06% | — | 2 | +80,000 | New | Q1 2026 | May 06, 2026 |